Puma Biotechnology, Inc.
PBYI· Nasdaq
PBYIPuma Biotechnology, Inc.
Filed Aug 11, 2014 · 10-Q · 42 days after period end · 0001564590-14-003464
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | -$38.84M | -$12.65M | -$14.75M | -$34.27K |
| EPS Diluted | -$1.29 | -$0.44 | -$0.74 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Puma Biotechnology, Inc. · CIK 1401667 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 11, 2014 · 42 d after period end
